Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03273 |
| Species: | Homo sapiens |
| Position : | chr9:137494462-137494862 |
| Year: | 2024 |
| Title: | Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 38378865 |
| Tissue: | endometrium |
| Tissue Ontology ID: | UBERON:0001295 |
| Cell Source: | 1390C1 |
| CVCL ID: | CVCL_UP48 |
| Cell Type: | endometrial stromal cell |
| Experiment Type: | CRISPR interference (CRISPRi) |
| High Throughput Method: | lentiSTARR-seq, lentiMPRA, scATAC-seq; MPRA; whole-genome sequencing |
| Low Throughput Method: | RT-RT-qPCR; FACS; EMSA; Reporter assay |
| Target gene : | COL5A1 |
| TF name : | GATA4 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| GATA4 | Factors involved in megakaryocyte development and platelet production | reactome | 111 |
| GATA4 | Notch-mediated HES/HEY network | pid | 48 |
| GATA4 | Physiological factors | reactome | 12 |
| GATA4 | Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | reactome | 13 |
| GATA4 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | reactome | 29 |
| GATA4 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| GATA4 | Hs_Heart_Development_WP1591_90186 | wikipathways | 28 |
| GATA4 | Hs_Serotonin_Receptor_2_and_ELK-SRF-GATA4_signaling_WP732_80010 | wikipathways | 13 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03274 | chr9:137494462-137494862 | endometrium | endometrial stromal cell | NA |
| E_03275 | chr9:137494462-137494862 | endometrium | endometrial stromal cell | NA |
| E_03276 | chr9:137494462-137494862 | endometrium | endometrial stromal cell | NA |
| E_03277 | chr9:137494462-137494862 | endometrium | endometrial stromal cell | NA |